JAA-F11

Bibliography

• RITTENHOUSE-DIAKUN K, XIA Z, PICKHARDT D, MOREY S, BAEK M-G, ROY R: Development and characterization of monoclonal antibody to T-antigen:(Galβ1-3GalNAc-α-O). Hybridoma (1998) 17(2):165-173.
   PubMed Web of Science ®Google Scholar
• HEIMBURG J, YAN J, MOREY S et al.: Inhibition of spontaneous breast cancer metastasis by anti-Thomsen–Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia (2006) 8(11):939-948.
   PubMed Web of Science ®Google Scholar
• FRIEDENREICH V: The Thomsen Hemagglutination Phenomenon: Production of a Specific Receptor Quality in Red Corpuscles by Bacterial Activity. Levin and Munksgaard, Copenhagen, Denmark (1930).
   Google Scholar
• RAHMAN AF, LONGENECKER BM: A monoclonal antibody specific for the Thomsen–Friedenreich cryptic antigen. J. Immunol. (1982) 129:2021-2025.
   PubMed Web of Science ®Google Scholar
• SPRINGER GF, DESAI PR: Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J. Natl. Cancer Inst. (1975) 54:335-339.
   PubMed Web of Science ®Google Scholar
• HAKOMORI S: Tumor-associated carbohydrate antigens. Ann. Rev. Immunol. (1984) 2:103-126.
   PubMedGoogle Scholar
• SPRINGER GF: T and Tn, general carcinoma autoantigens. Science (1984) 224(4654):1198-1206.
   PubMed Web of Science ®Google Scholar
• IRAZOQUI FJ, NORES GA: Thomsen–Friedenreich disaccharide immunogenicity. Curr. Cancer Drug Targets (2003) 3(6):433-443.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER F, KEMMNER W, HAENSCH W et al.: Overexpression of sialyltransferase CMP-sialic acid:Galβ1,3GalNAc-R α6-sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res. (2001) 61:4605-4611.
   PubMed Web of Science ®Google Scholar
• TAKANAMI I: Expression of Thomsen–Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol. Reports (1999) 6:341-344.
   PubMed Web of Science ®Google Scholar
• DIPPOLD W, STEINBORN A, MEYER ZUM BUSCHENFELDE KH: The role of the Thomsen–Friedenreich antigen as a tumor-associated molecule. Environ. Health Perspect. (1990) 88:255-257.
   PubMed Web of Science ®Google Scholar
• SPRINGER GF, DESAI PR: Cross-reacting carcinoma-associated antigens with blood group and precursor specificities. Transplant. Proc. (1977) 9(1):1105-1111.
   PubMed Web of Science ®Google Scholar
• TAKANAMI I: Expression of Thomsen–Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma. Oncol. Reports (1999) 6:341-344.
   PubMed Web of Science ®Google Scholar
• BLIXT O, HEAD S, MONDALA T et al.: Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA (2004)101(49):17033-17038.
   Google Scholar
• DE BENTZMANN S, DUPUTIT PR, BAJOLET-LAUDEINAT O et al.: Asialo GM1 is a receptor for Pseudomonas aeruginosa adherance to regenerating respiratory epithelial cells. Infect. Immun. (1996) 64:1582-1588.
   PubMed Web of Science ®Google Scholar
• KOVACIC N, MUTHING J, MARUSIC A: Immunohistochemical and flow cytometric analysis of glycosphingolipid expression in mouse lymphoid tissues. J. Histochem. Cytochem. (2000) 48:1677-1689.
   PubMed Web of Science ®Google Scholar
• ABDI EA, KAMITOMO V J, MCPHERSON T A et al.: Radioiodinated peanut lectin: clinical use as a tumour-imaging agent and potential use in assessing renal-tubular function. Eur. J. Nucl. Med. (1986) 11(9):350-354.
   PubMedGoogle Scholar
• MILLER GM, ANDRES ML, GRIDLEY DS: NK cell depletion results in accelerated tumor growth and attenuates the anti-tumor effect of total body irradiation. Int. J. Oncol. (2003) 1585-1592.
   PubMed Web of Science ®Google Scholar
• YU L, ANDREWS N, ZHAO Q et al.: Galectin-3 interaction with Thomsen–Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J. Biol. Chem. (2007) 282(1):773-781.
   PubMed Web of Science ®Google Scholar
• GLINSKY VV, GLINSKY GV, RITTENHOUSE-OLSON K et al.: The role of Thomsen–Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res. (2001) 61:4851-4857.
   PubMed Web of Science ®Google Scholar
• GLINSKY VV, HUFLEJT ME, GLINSKY GV, DEUTSCHER SL, QUINN TP: Effects of Thomsen–Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res. (2000) 60:2584-2588.
   PubMed Web of Science ®Google Scholar
• GLINSKII OV, HUXLEY VH, TURK JR et al.: Continuous real time ex vivo epifluorescent video microscopy for studying cancer cell interactions with dura mater microvasculature. Clin. Exp. Metastasis (2003) 20:451-458.
   PubMed Web of Science ®Google Scholar
• GLINSKII OV, HUXLEY VH, GLINSKY GV, PIENTA KJ, RAZ A, GLINSKY VV: Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia (2005) 5:522-527.
   Google Scholar
• GLINSKY VV: Intravascular cell-to-cell adhesive interactions and bone metastasis. Cancer Metastasis Rev. (2006) 25:531-540.
   PubMed Web of Science ®Google Scholar
• DESSUREAULT S, KOVEN I, REILLY RM et al.: Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint AD). Breast Cancer Res. Treat. (1997) 45(1):29-3.
   PubMed Web of Science ®Google Scholar
• KURTENKOV O, MILJUKHINA L, SMORODIN J et al.: Natural IgM and IgG antibodies to Thomsen–Friedenreich (T) antigen in serum of patients with gastric cancer and blood donors. Acta Oncol. (1999) 38(7):939-943.
   PubMed Web of Science ®Google Scholar
• DESAI PR, UJJAINWALA LH, CARLSTEDT SC, SPRINGER GF: Anti-Thomsen–Friedenreich (T) antibody-based ELISA and its application of human breast carcinoma detection. J. Immunol. Methods (1995) 188:175-185.
   PubMed Web of Science ®Google Scholar
• JANSSON B, BORREBACK CAK: The human repertoire of antibody specificities against Thomsen–Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies. Cancer Immunol. Immunother. (1992)34:294-298.
   PubMed Web of Science ®Google Scholar
• MONTEIRO MA, CHAN KH, RASKO DA et al.: Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem. (1998) 273(19):11533-11543.
   PubMed Web of Science ®Google Scholar
• KURTENKOV O, KLAAMAS K, RITTENHOUSE-OLSON K et al.: Expression of tumor-associated Thomsen–Friedenreich (T) antigen in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol. Invest. (2002) 31:191-204.
   PubMed Web of Science ®Google Scholar
• THORS C, JANSSON B, HELIN H, LINDER E: Thomsen–Friedenreich oncofetal antigen in Schistosoma mansoni: localization and immunogenicity in experimental mouse infection. Parasitology (2006)132:72-81.
   Google Scholar
• KURTENKOV OA, KLAAMAS K, MILJUKHINA L: The lower level of natural anti-Thomsen–Friedenreich antigen (TFA) agglutinins in sera of patients with gastric cancer related to ABO(H) blood-group phenotype. Int. J. Cancer (1995) 60:781-785.
   PubMed Web of Science ®Google Scholar
• KURTENKOV O, KLAAMAS K, SERGEYEV B, CHUZMAROV V, MILJUKHINA L, SHLJAPNIKOVA L: Better survival of Helicobacter pylori infected patients with early gastric cancer is related to a higher level of Thomsen–Friedenreich antigen-specific antibodies. Immunol. Invest. (2003) 32(1-2):83-93.
   PubMed Web of Science ®Google Scholar
• SPRINGER GF: Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis and immunotherapy. J. Mol. Med. (1997) 75:594-602.
   PubMed Web of Science ®Google Scholar